Relacionan una proteína con el desarrollo de células cancerosas de colon, páncreas y cerebro

by Fundación Andaluza para la Divulgación de la Innovación y el Conocimiento

Un equipo de investigación de las Universidades de Almería, Miguel Hernández de Alicante y Zaragoza, en colaboración con la fundación FISABIO, ha determinado las características de la proteína ...

Read more

Developed a new system that allows knowing the right dose of radiotherapy in people with cancer

by Instituto de Investigación Biosanitaria - Ibs Granada

The Medical Physics research group of the Biosanitary Research Institute of Granada (ibs.GRANADA) has managed to develop a technology through photodiodes and phototransistors that allows the dose of r...

Read more

Drug previously used for hypertension found to work on glioblastoma brain tumour

by IRB Lleida. Institut de Recerca Biomèdica

Glioblastoma is the most common and aggressive brain cancer, due to its ability to evade the immune system and grow. The Calcium cellular signalling research group at the Institute for Research in Bio...

Read more

A study with the participation of VHIO leads to approval of first-line treatment with pembrolizumab for most patients with metastatic or recurrent head and neck squamous cancer

by VHIO

Pembrolizumab, a monoclonal antibody which binds with the protein PD-1 to help immune cells destroy more cancer cells, is seeing a steady increase in its indications. Now, the KEYNOTE-048 phase III cl...

Read more

Researchers at IRB Barcelona rejuvenate mouse organs through cellular reprogramming

by IRB Barcelona - Instituto de Investigación Biomédica

Headed by ICREA researcher Dr. Manuel Serrano, scientists from the Cellular Plasticity and Disease lab at IRB Barcelona have managed to rejuvenate some mouse organs and tissues via cell reprogramming....

Read more

Researchers identify the biological basis responsible for developing breast cancer in patients with mutations in BRCA1

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

Mutations in the BRCA1 gene are inherited from parents to children and carry a high risk of breast and ovarian cancer. One in 1,000 people are carriers of mutations in this gene, and between 45 and 85...

Read more

CNIO researchers find a way to increase effectiveness of radiotherapy for brain metastasis

by CNIO - Centro Nacional de Investigaciones Oncológicas

They found that a simple blood test can help detect patients with resistance to brain radiotherapy and identified a drug that might reverse it. A multi-centre clinical study is now under way to valida...

Read more

Triple therapy shows major benefits in the treatment of metastatic prostate cancer

by VHIO

A study performed by the European PEACE consortium, in which the Vall d’Hebron Institute of Oncology (VHIO), part of the Vall d’Hebron Campus, participated, has shown how adding abiraterone to and...

Read more

Spanish researchers discover new genetic pathways causing tumor transformation in a rare type of lymphoma

by CIMA - Centro de Investigación Médica Aplicada

Researchers at Cima Universidad de Navarra have discovered new genetic pathways that cause the mutation of healthy cells and the tumor transformation in this type of lymphoma. This finding could contr...

Read more

Una técnica utilizada en análisis de sangre permitiría diagnosticar tumores en líquidos pleurales y peritoneales

by Universidad del País Vasco

Hay una técnica que podría suplir esas carencias: la citrometría de flujo. Este método, ampliamente utilizado en el estudio de la sangre, está poco aprovechada en el análisis de los líquidos pl...

Read more

RAD51 once again proves its precision as a biomarker for identifying and stratifying sub-type HRD tumours

by VHIO

Tools that currently help to identify which patients are more sensitive to this type of treatment have low specificity in advanced cancers. The Vall d’Hebron Institute of Oncology (VHIO) has develop...

Read more

The hidden cells behind B-cell acute lymphoblastic leukemia relapse spotlighted for the first time

by Fundació Sant Joan de Déu

Drs. Susana Rives, Montserrat Torrebadell and Nerea Vega (IRSJD) participate in a study led by Dr. Pablo Menéndez, group leader at the Josep Carreras Leukaemia Research Institut, who has identified a...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream